NCT03299387View on ClinicalTrials.gov

INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 28, 2017

Primary Completion Date

July 5, 2018

Study Completion Date

July 5, 2018

Conditions
Urinary Tract Infections
Interventions
DRUG

Nitrofurantoin

Participants will receive oral Nitrofurantoin 100 mg twice daily for 7 days

DRUG

Gentamicin

Participants will receive intravesical via catheter Gentamicin solution 25 mg in 50cc for 3 days

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03299387 - INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI | Biotech Hunter | Biotech Hunter